AP Pharma Inc.
123 Saginaw Drive
Redwood City,
CA 94063
United States - Map
Phone: 650-366-2626
Fax: 650-365-6490
Web Site: http://www.appharma.com
| A.P. Pharma, Inc., a specialty pharmaceutical company, engages in developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology. Its lead product candidate is APF530, which completed pivotal Phase III clinical trial for the prevention of chemotherapy-induced nausea and vomiting. The companys product candidate also includes APF112, which incorporates anesthetic, mepivacaine and is designed to provide relief from post-surgical pain and to minimize the use of morphine-like drugs, or opiates. Its pre clinical product candidate APF580 incorporates an opiate into its Biochronomer technology and is designed to provide analgesia lasting at least seven days from a single injection. A.P. Pharmas Biochronomer technology is also used for various applications in therapeutic areas, including pain management, prevention of nausea, control of inflammation, and treatment of ophthalmic diseases. The company was formerly known as Advanced Polymer Systems, Inc. and changed its name to A.P. Pharma, Inc. in May 2001. A.P. Pharma, Inc. was founded in 1983 and is based in Redwood City, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Ronald J. Prentki , 51
Chief Exec. Officer, Pres |
$
196.00K | N/A | Dr. John Barr Ph.D., 49
Sr. VP of R&D |
N/A
| N/A | Mr. John B. Whelan MBA, 47
Chief Financial Officer, Principal Accounting Officer and VP of Fin. |
N/A
| N/A | Mr. Julian N. Stern , 83
Sec. |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.20% Nasdaq 
0.14%
Profile
